ArticleJournal of economic entomology2026
Biological costs and benefits of selective breeding for disease resistance using marker-assisted or field-based selective breeding in honey bees (Apis mellifera).
Article in Journal of economic entomology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Honey bee (Apis mellifera L.) breeders seek to enhance disease resistance by selecting for behavioral resistance traits such as hygienic behavior and Varroa-sensitive hygiene. However, traditional phenotypic assays for these traits are labor-intensive, limiting scalability. Antennal protein biomarkers correlated with these behaviors offer a promising tool for marker-assisted selection (MAS), potentially increasing phenotyping efficiency and accelerating genetic gains. This study evaluated the performance of honey bee colonies from 4 stocks: those selected using field-based phenotypic assays (FAS) or MAS, versus unselected domestic stock (BEN) or imported commercial (IMP) stock. Colonies were situated across 3 distinct geographic regions and were managed with or without acaricide treatment for the treatment of Varroa destructor mites to assess both the benefits of resistance under parasitic stress and potential fitness costs under low-stress conditions. Across regions, MAS and FAS stocks performed comparably in productivity and pathogen metrics and were equal to or more productive than the unselected BEN and IMP stocks. At specific locations and time points, MAS and FAS colonies maintained significantly lower Varroa destructor populations in the absence of acaricides, demonstrating enhanced natural mite suppression. Selection for hygienic behavior was positively associated with colony health and fitness, with no evidence of biologically meaningful trade-offs. Increased overwinter food consumption in selected colonies reflected larger fall populations rather than a direct cost of resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.